WIM
ABBV icon

Waverton Investment Management’s AbbVie ABBV Stock Holding History

Waverton Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10,678
Closed -$809K – 47
2019
Q3 		$809K Sell
10,678
-1,435
-12% -$98.4K 0.04% 61
2019
Q2 		$881K Buy
12,113
+415
+4% +$32.6K 0.04% 64
2019
Q1 		$943K Buy
11,698
+252
+2% +$20.6K 0.05% 56
2018
Q4 		$1.05M Buy
11,446
+636
+6% +$55.9K 0.06% 52
2018
Q3 		$1.02M Sell
10,810
-1,950
-15% -$185K 0.05% 54
2018
Q2 		$1.18M Sell
12,760
-284
-2% -$27.7K 0.07% 47
2018
Q1 		$1.24M Buy
13,044
+471
+4% +$51.7K 0.07% 46
2017
Q4 		$1.22M Buy
12,573
+2,032
+19% +$192K 0.07% 46
2017
Q3 		$937K Buy
10,541
+86
+0.8% +$6.55K 0.06% 53
2017
Q2 		$758K Buy
10,455
+286
+3% +$19.2K 0.05% 62
2017
Q1 		$663K Buy
+10,169
New +$639K 0.04% 84

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Waverton Investment Management's ABBV Position: Q4 2019 in Review

Waverton Investment Management sold out of AbbVie (ABBV) in Q4 2019, closing a stake of 10,678 shares — an estimated $809K sold.

Waverton Investment Management first reported a position in ABBV in Q1 2017 and held it in 11 quarters. The position peaked at $1.24M in Q1 2018. 2,243 funds tracked by Wall St. Rank hold ABBV as of Q4 2019.

  • Waverton Investment Management reported no remaining AbbVie position as of Q4 2019 after selling out during the quarter.
  • Waverton Investment Management sold 10,678 AbbVie shares in Q4 2019, an estimated $809K.
  • Waverton Investment Management first reported a position in AbbVie in Q1 2017 and held it in 11 quarters.
  • Waverton Investment Management's AbbVie position peaked at $1.24M in Q1 2018.
  • 2,243 funds tracked by Wall St. Rank held AbbVie as of Q4 2019.

Based on Waverton Investment Management's 13F filing for Q4 2019, filed 22 Jan 2020.